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Ablation and Spectral Characteristics of Fibrillation. Background: Complex fractionated atrial
electrograms (CFAE) have been considered to be helpful during catheter ablation of atrial fibrillation (AF).
The purpose of this study was to analyze the characteristics of CFAEs recorded during sinus rhythm (SR)
and AF, and to determine their relationship to perpetuation of AF and clinical outcome.
Methods and Results: Antral pulmonary vein isolation (APVI) was performed in 34 consecutive patients
(age = 59 ± 10 years) with paroxysmal AF who presented in SR. Time- and frequency-domain character-
istics of electrograms recorded from the same sites in the coronary sinus (CS) were analyzed during SR
and AF, before and during isoproterenol infusion. There was a modest correlation in fractionation index
(FI: change in the direction of depolarization, r = 0.40, P = 0.001) and complexity index (CI: change in
the polarity of depolarization, r = 0.41, P = 0.001), but not in the dominant frequency (DF) between SR
and AF. There was no relationship between the DF and CI or FI during AF. Isoproterenol was associated
with an increase in DF during AF (6.6 ± 0.9 vs 5.1 ± 0.6 Hz, P < 0.001) but had no effect on CI or FI (P =
0.6). A higher CI (58.3 ± 21.0/s vs 38.0 ± 21.0/s, P < 0.01), and FI (123.5 ± 44.8/s vs 75.6 ± 44.6/s, P <
0.01) during AF were associated with a lower likelihood of termination of AF during APVI and a higher
probability of recurrent AF after ablation. Ratio of FI during AF to SR was also higher when AF persisted
than terminated after APVI (29.7 ± 12.4 vs 19.1 ± 9.7, P = 0.002). However, time- or frequency-domain
parameters during SR were not predictive of termination or clinical outcome.
Conclusions: Structural and functional properties of the atrial myocardium during AF contribute to
electrogram complexity, which may indicate the presence of extra-PV mechanisms of AF that are not
eliminated by APVI. Mapping of complex electrograms in SR is not likely to be sufficient to identify drivers
of AF. (J Cardiovasc Electrophysiol, Vol. 22, pp. 851-857, August 2011)
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Complex fractionated atrial electrograms (CFAEs) have
been considered helpful to identify target sites in both atria
and coronary sinus (CS) during catheter ablation of atrial
fibrillation (AF).1-4 CFAEs are thought to indicate sites of
conduction slowing or block, wave-front collision, anchor
points for reentrant circuits, sites of wave-break and fibrilla-
tory conduction at the periphery of high frequency sources,
and autonomic innervation.5-8 Electrogram fractionation and
complexity may also develop due to the structural properties
of the underlying tissue that cause summation of activation
from overlapping muscle fibers or anisotropy.9 It is not clear
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whether CFAEs due to structural or functional properties play
a critical role in the genesis of AF. The relationship between
electrogram complexity during sinus rhythm (SR) and AF
also remains unclear.
The purpose of this study was to investigate the charac-
teristics and mechanisms of CFAEs in paroxysmal AF by
examining the time- and frequency-domain characteristics
of electrograms recorded in the CS during SR and AF before
and during infusion of isoproterenol and their relationship to
elimination of AF during ablation.
Methods
Study Subjects
The subjects of this study were 34 consecutive patients
with paroxysmal AF who presented to the electrophysiology
laboratory in SR for de novo radiofrequency catheter ablation
of AF. The mean age of the patients was 59 ± 10 years. There
were 28 men and 6 women. AF was first diagnosed 7 ±
6 years prior to referral. The mean left ventricular ejection
fraction was 0.56 ± 0.07 and the mean left atrial diameter
was 42 ± 7 mm. Structural heart disease was present in 14
patients (41%): hypertensive heart disease in 11, coronary
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TABLE 1
Clinical Characteristics
Termination of AF during RFA Freedom from AF
No (N = 11) Yes (N = 23) P No (N = 11) Yes (N = 23) P
Age (years) 55 ± 14 62 ± 6 0.1 56 ± 8 61 ± 10 0.2
Male/female 9/2 19/4 1.0 10/1 18/5 0.4
Duration of AF (years) 7.7 ± 6.9 6.7 ± 6.4 0.7 6.9 ± 6.5 7.2 ± 6.7 0.9
Structural heart disease 4 (36) 10 (43) 0.7 7 (50) 7 (35) 0.5
Hypertension 3 8 6 5
Coronary artery disease 0 2 1 1
Nonischemic CM 1 1 1 1
Amiodarone before RFA 2 3 0.6 2 3 1.0
Left atrial diameter (mm) 42 ± 7 43 ± 8 0.7 40 ± 4 44 ± 8 0.1
LV ejection fraction (%) 55 ± 6 57 ± 9 0.5 55 ± 7 56 ± 7 0.5
Data are shown as mean ± SD. Percent values are shown in parentheses. Freedom from AF was assessed after a single ablation procedure. AF = atrial
fibrillation; RFA = radiofrequency catheter ablation; LV = left ventricle; CM = cardiomyopathy.
artery disease in 2, and a nonischemic cardiomyopathy in 2
patients (Table 1).
Electrophysiologic Study and Radiofrequency Catheter
Ablation
All patients provided informed written consent for this
study. An electrophysiological study was performed in the
fasting state under conscious sedation using midazolam and
fentanyl. Treatment with antiarrhythmic medications, except
for amiodarone in 2 patients, was discontinued 5 half-lives
before the procedure. Treatment with amiodarone was dis-
continued 8 weeks prior to the procedure. Vascular access
was obtained through a femoral vein. A decapolar (Biosense
Webster, Diamond Bar, CA, USA) catheter with 2.5 mm
interelectrode spacing was positioned in the CS and used
for recording electrograms and atrial pacing. The position
of the CS catheter was confirmed periodically by fluo-
roscopy throughout the procedure. Because the CS catheter
has a stable position throughout the procedure, electrograms
recorded from the distal and middle CS were analyzed in this
study. After the transseptal puncture, systemic anticoagula-
tion was achieved with intravenous heparin to maintain an
activated clotting time of 300–350 seconds. The pulmonary
veins (PVs) were mapped with a decapolar ring catheter
(Lasso, Biosense Webster). An open-irrigation, 3.5-mm-tip
deflectable catheter (Thermocool, Biosense Webster) was
used for mapping and ablation. Bipolar electrograms were
displayed at filter settings of 30–500 Hz during the proce-
dure (EPMed Systems). Electrograms also were recorded at
a bandpass of 0.5–200 Hz for off-line spectral analysis.
An electroanatomical mapping system (Carto, Biosense
Webster) was used to construct the 3-dimentional geometry
of the left atrium and PVs Antral pulmonary vein isolation
(APVI) was performed to isolate all PVs Radiofrequency
energy applications were delivered at a maximum power of
35 W at a flow rate of 30 mL/min and a maximum temperature
of 48◦C. Near the ostium of the PVs and on the posterior left
atrium, radiofrequency energy was delivered at a maximum
power of 25 W at a flow rate of 17 mL/min.
Study Protocol
The study protocol was approved by the Institutional Re-
view Board. AF was induced by either isoproterenol infusion
up to 20 μg/min (26 patients) or rapid atrial pacing from the
CS (8 patients) prior to ablation. Electrograms from the CS
were recorded for 60 seconds: (1) during sinus rhythm at
baseline; (2) during isoproterenol infusion at the highest in-
fusion rate both in SR and AF (60 seconds of induction); and
(3) during AF ≥ 10 minutes after isoproterenol washout or
after AF induction by using rapid atrial pacing from the CS.
Electrograms recorded from the CS were processed and
analyzed off-line in the MatLab environment (MathWorks,
Natick, MA, USA) using custom software as described pre-
viously.10 All data and electrograms were reviewed manually
and appropriateness of detection was validated. Electrogram
analysis was performed during SR and AF as follows:
(i) Electrogram analysis during SR: Bipolar electrograms
with the largest amplitude in each 10-second recording sam-
ple were used for analysis. The dominant frequency (DF)
was defined as the frequency of the highest peak of the
periodogram using Fast Fourier Transformation. The spec-
tral pattern was categorized as: Type 1- a single frequency
component constituting >90% of the total power; or Type
2- multiple frequency components, each with ≥20% of the
maximum power (Fig. 1). The characteristics of atrial elec-
trograms were also analyzed in the time-domain: (1) duration
of the atrial electrogram, measured from the earliest to the
latest atrial electrogram deflection; (2) amplitude, measured
as the voltage difference between the maximum positive and
minimum negative deflection of the electrogram; (3) frac-
tionation index (FI), the number of changes in the direction
of depolarization; and (4) complexity index (CI), the number
of changes in the polarity of the depolarization (Fig. 1).
(ii) Electrogram Analysis during AF: QRS complexes
were subtracted first and spectral and time domain analy-
ses were performed as described previously.10,11 In addition
to the DF, the mean amplitude was determined as the mean
of the maximum 60 electrogram amplitudes in a sampling
window, and parameters of fractionation were determined as
the frequency of change in the direction of depolarization
(FI) and polarity of depolarization (CI) per second (Fig. 1).
The following parameters were systematically analyzed:
(1) time- and frequency-domain characteristics during SR
and AF; (2) effect of isoproterenol on time- and frequency-
domain characteristics during SR and AF; (3) relationship
between frequency- and time-domain characteristics; and (4)
relationship between time- and frequency-domain character-
istics and termination of AF during APVI and clinical out-
come after catheter ablation.
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Figure 1. Analysis of atrial electrograms recorded in coronary sinus (CS) during sinus rhythm (SR, Panels A–C) and atrial fibrillation (AF, Panels D–F)
in time- and frequency-domains. A single electrogram during SR is shown in Panel (A) and a 2-second recording of electrograms during AF is shown in
Panel (D). Boxed area in Panel (D) is enlarged as Panel (E) for better resolution. Fractionation index (FI) was defined as the change in the direction of
depolarization (open circles, Panels A and E), whereas complexity index (CI) was defined as the change in the polarity (full circles, Panels A and E). During
SR, the spectral pattern was categorized as type 1 (Panel B) and type 2 (Panel C) periodograms. Panel (F) shows the periodogram of frequency-domain
analysis during AF. DF = dominant frequency.
Post Ablation Care and Follow-Up
All patients were treated with intravenous heparin after
the procedure, and were discharged home the next day on
warfarin and low molecular weight heparin until the inter-
national normalized ratio was >2.0. Patients were first seen
in an outpatient clinic 3 months after the ablation and every
6 months thereafter. Patients were contacted periodically by a
nurse and were asked to call a clinical coordinator whenever
they experienced symptoms suggestive of an arrhythmia. A
30-day auto-triggered event monitor was provided to all pa-
tients 6 months after ablation.
A successful clinical outcome was defined as freedom
from recurrent atrial arrhythmias (≤30 seconds) in the ab-
sence of antiarrhythmic drug therapy after a single abla-
tion procedure. The mean duration of follow-up was 13 ± 5
months.
Statistical Analysis
Continuous variables are expressed as mean ± 1 standard
deviation and were compared by Student’s t-test. Categori-
cal variables were compared by Chi-square analysis or with
Fisher’s exact test where appropriate. Pearson’s correlation
coefficients were used to determine the relationship between
various parameters. A P < 0.05 indicated statistical signifi-
cance.
Results
Time- and Frequency-Domain Characteristics During SR
During SR, the mean number of changes (per electrogram)
in the direction (FI) and polarity (CI) of the electrograms
were 4.1 ± 1.3 and 2.9 ± 1.1, respectively. There was a direct
correlation between FI and CI (r = 0.88, P < 0.001, Fig. 3).
The mean DF during SR was 54.9 ± 19.4 Hz. There was a
statistically significant direct linear correlation between the
DF and CI (r = 0.31, P = 0.01), but not between the DF and
FI (r = 0.18, P = 0.14).
The mean amplitude and duration of the electrograms
were 2.9 ± 2.0 mV and 39.7 ± 9.0 ms, respectively. There
was a negative correlation between the amplitude and FI (r =
−0.30, P = 0.01, Fig. 3) and between the amplitude and du-
ration (r = −0.35, P = 0.004), but not between the amplitude
and DF (r = 0.22, P = 0.08) or between the amplitude and
CI (r = −0.21, P = 0.10).
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Figure 2. Time- and frequency-domain characteristics of CS electrograms in 2 patients who did not (Panel A) and did (Panel B) have recurrent AF after
APVI. In SR (left panel) electrogram characteristics were similar between the 2 patients. However, during AF, FI, and CI were higher in the patient who had
recurrent AF after APVI. Abbreviations as in Figure 1.
Time- and Frequency-Domain Characteristics During AF
During AF, FI and CI were 90.1 ± 49.5/s and 44.1 ±
22.9/s, respectively, at baseline. There was a direct correla-
tion between FI and CI during AF (r = 0.96, P < 0.001,
Fig. 3). The mean DF was 5.2 ± 0.7 Hz. There was no corre-
lation between the DF and FI (r = 0.17, P = 0.2) or between
the DF and CI (r = 0.22, P = 0.07).
The mean amplitude was 0.58 ± 0.33 mV. There was
a negative correlation between the amplitude and CI (r =
−0.55, P < 0.001), and between the amplitude and FI (r =
−0.55, P < 0.001, Fig. 3). There was no significant rela-
tionship between the amplitude and DF (r = −0.04, P =
0.78).
Relationship between Time- and Frequency-Domain
Parameters During SR and AF
There was a direct relationship between the amplitude (r =
0.44, P < 0.001), FI (r = 0.40, P = 0.001) and CI (r = 0.41,
P = 0.001) during SR and AF. There was no relationship
between DF during SR and AF (r = 0.01, P = 0.96).
During SR, sites that displayed a type 2 periodogram had
a longer duration (43.7 ± 10.0 vs 36.4 ± 6.4, P = 0.001),
higher FI (4.4 ± 1.7 vs 3.8 ± 0.7, P = 0.045) and CI (3.2 ±
1.5 vs 2.6 ± 0.7, P = 0.045), but a lower amplitude (2.07 ±
1.14 vs 3.60 ± 2.30, P = 0.002) in the time-domain than
sites that displayed a type 1 periodogram. However, during
AF, there was no difference in FI (85.7 ± 45.7/s vs 95.4 ±
54.2/s, P = 0.4), CI (41.8 ± 19.7/s vs 46.9 ± 26.2/s, P =
0.4) or amplitude (0.58 ± 0.32 vs 0.58 ± 0.35, P = 0.9)
between sites with a type 1 and 2 periodogram. The DF was
also similar between sites with a type 1 or 2 periodogram
during both SR and AF (P = 0.3 and P = 0.6, respectively).
Effect of Isoproterenol
Isoproterenol infusion resulted in a decrease in the SR
cycle length from 990 ± 161 ms to 583 ± 143 ms (P <
0.001) and an increase in amplitude from 2.59 ± 1.70 mV to
3.88 ± 2.89 mV (P< 0.001). There was no change in the DF
during SR (55.7 ± 21.2 Hz vs 56.7 ± 24.2 Hz, P = 0.6) or
duration of electrograms (39.4 ± 8.8 ms vs 38.2 ± 8.7 ms,
P = 0.2). Isoproterenol did not have an effect on FI or CI
during SR (P = 0.1 and 0.4, respectively).
During AF, isoproterenol resulted in an increase in the
amplitude (0.67 ± 0.45 mV vs 0.53 ± 0.33 mV, P = 0.01)
and DF (6.6 ± 0.9 Hz vs 5.1 ± 0.6 Hz, P < 0.001), but did not
have an effect on FI and CI (P = 0.8 and 0.6, respectively).
There was no difference in DF (6.6 ± 0.9 Hz vs 6.6 ±
0.9 Hz, P = 0.9), FI (87.4 ± 38.0/s vs 109.6 ± 52.6/s,
P = 0.1), CI (45.3 ± 17.0/s vs 53.4 ± 25.9/s, P = 0.2),
or amplitude (0.70 ± 0.43 vs 0.63 ± 0.49, P = 0.6) between
sites with a type 1 and 2 periodogram during isoproterenol
infusion.
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Figure 3. Relationship between the frac-
tionation and complexity indices, and be-
tween amplitude and the fractionation in-
dex during SR (Panel A) and AF (Panel
B). Abbreviations as in Figure 1.
Time- and Frequency-Domain Parameters and
Termination of AF during Ablation
AF terminated in 23 of 34 patients (68%) during ablation:
to sinus rhythm in 21 and to an atrial tachycardia/flutter in 2.
There was no difference in clinical characteristics among pa-
tients in whom AF did and did not terminate during ablation
(Table 1).
During SR, prior to ablation, the amplitude, duration, DF,
spectral pattern (type 1 or 2), FI and CI were similar among
patients who did and did not have termination of AF during
ablation (Table 2).
During AF, before ablation, the DF was also similar be-
tween patients in whom AF did and did not terminate during
APVI. However, the mean FI and CI were lower and the
amplitude was higher in patients who had termination of AF
than who did not (Table 2).
To determine the effect of AF on fractionation and com-
plexity of electrograms, FI and CI during SR and AF were
compared. Patients who did not have termination of AF dur-
ing ablation had a higher ratio of FI during AF to FI during
SR (FI AF/SR) than patients in whom AF terminated (29.7 ±
12.4 vs 19.1 ± 9.7, P = 0.002). There also was a higher ratio
of CI during AF to CI during SR (CI AF/SR) in patients who
did not have termination of AF during ablation than who did
(19.9 ± 9.1 vs 14.5 ± 6.9, P = 0.03).
Fractionation and Complexity During SR and AF and
Clinical Outcome
During a mean follow-up of 13 ± 5 months after a single
ablation procedure, 20 patients (59%) were in sinus rhythm
in the absence of antiarrhythmic drug therapy. Among the 14
patients with recurrent atrial arrhythmias, 11 had AF and 3
had atrial tachycardia or flutter. There was no difference in
clinical characteristics among patients who did and did not
remain free from recurrent AF after the ablation (Table 1).
The FI and CI were higher during AF, but not during SR,
in patients who had recurrent AF than who did not (Table 2
and Fig. 2). Patients who had recurrent AF also had a higher




The main findings of this study are: (1) there is a direct
correlation between change in the direction (fractionation
index) and change in the polarity (complexity index) of elec-
trograms during SR and AF; (2) there is an inverse correla-
tion between the amplitude and CI and FI of electrograms
in SR and AF; (3) there is no relationship between DF and
CI or FI of electrograms in AF; (4) there is a modest direct
relationship in amplitude, FI and CI (but not DF) between
electrograms recorded in SR and in AF; (5) isoproterenol is
associated with an increase in amplitude both in SR and AF,
and an increase in DF only during AF; (6) FI and CI are
lower among patients who are more likely to remain in SR
after APVI; and (7) type I or II electrograms are not predic-
tive of complexity of electrograms or DF or clinical outcome
after APVI.
856 Journal of Cardiovascular Electrophysiology Vol. 22, No. 8, August 2011
TABLE 2
Characteristic CS Electrograms
Termination of AF During RFA Freedom from AF
No (n = 20) Yes (n = 46) No (n = 22) Yes (n = 44)
Duration (ms) SR 39.7 ± 8.6 39.8 ± 9.2 40.0 ± 8.6 39.6 ± 9.2
Type 2 spectral pattern SR 7 (35) 23 (50) 9 (41) 21 (48)
DF (Hz) SR 57.2 ± 17.7 53.9 ± 20.2 52.0 ± 14.8 56.3 ± 21.3
AF 5.2 ± 0.8 5.2 ± 0.7 5.1 ± 0.8 5.2 ± 0.7
Amplitude (mV) SR 2.83 ± 1.69 3.93 ± 2.14 2.52 ± 1.27 3.09 ± 2.27
AF 0.42 ± 0.17 0.65 ± 0.36† 0.54 ± 0.30 0.60 ± 0.35
Fractionation index SR 4.4 ± 1.1 4.0 ± 1.3 4.2 ± 1.0 4.0 ± 1.4
AF 123.5 ± 44.8 75.6 ± 44.6† 108.9 ± 48.1 80.7 ± 04.1∗
Complexity index SR 3.2 ± 0.9 2.7 ± 1.2 3.0 ± 0.8 2.8 ± 1.3
AF 58.3 ± 21.0 38.0 ± 21.0† 52.1 ± 25.0 40.1 ± 20.9∗
Data are shown as mean ± SD. Percent values are shown in parenthesis. Abbreviations as in Table 1.
∗P < 0.05.
†P < 0.01.
Taken together these findings suggest that structural and
functional properties contribute to electrogram fractionation
and complexity and that fractionation and complexity may
indicate the presence of extra-PV mechanisms as perpetua-
tors of AF that are not eliminated by APVI.
Electrogram Complexity During SR and AF
A finding of this study is that change in the direction
(fractionation) and polarity (complexity) of electrograms are
highly correlated both in SR and AF. Complex electrograms
appear to have smaller amplitudes than other electrograms,
possibly due to preexisting fibrosis and multiplicity of di-
rections of wave-front propagation in multiple tissue layers.
Change in the direction and polarity of electrograms are most
likely due to anisotropy and complex histological organiza-
tion of the underlying myocardium.12 A modest linear rela-
tionship between the complexity of electrograms recorded in
SR and during AF may suggest that fixed structural and/or
electrophysiologic properties of the myocardium contribute
to the complexity of the electrograms.
Complexity and DF
There was no relationship between the DF and complexity
of electrograms during AF suggesting that the 2 parameters
often used to map drivers of AF indicate different mecha-
nisms of AF. DF is influenced both by the frequency (cycle
length) and also amplitude (power) of electrograms analyzed.
At a given site, an electrogram component with a large am-
plitude but a long cycle length is more likely to be identified
as the spectral component indicating DF than a small am-
plitude, complex fractionated electrogram with a short cycle
length that may indeed represent a critical driver. Therefore,
DF mapping in the absence of simultaneous high-density
recordings may not be sufficient to accurately identify criti-
cal drivers of AF.
Effect of Isoproterenol on Electrogram Characteristics
Isoproterenol increased the amplitude of electrograms
both in SR and during AF. Isoproterenol is likely to in-
crease the electrochemical gradients across the cell mem-
brane, which facilitates larger action potentials. Isoproterenol
was also associated with an increase in DF only during AF;
however, it had no effect on complexity and fractionation of
electrograms. Isoproterenol may increase DF by a number of
mechanisms: (1) an increase in automaticity and frequency
of discharges from an automatic focus;13 (2) a decrease in
effective refractory period and action potential duration;14 or
(3) an increase in conduction velocity leading to a shorter
cycle length.15
Because there was no increase in the complexity and frac-
tionation indices despite an increase in DF during isopro-
terenol infusion, it may be that complexity and fractionation
of electrograms are primarily due to preexisting structural
properties rather than due to functional response to a higher
activation rate that otherwise would be expected to promote
wave-break, fractionation and fibrillatory conduction.6,16
However, it should be noted that isoproterenol also increases
the conduction velocity and may have led to an increase in the
threshold activation frequency at which wavebreak occurs.
Therefore, the effects of isoproterenol on DF and conduc-
tion velocity may have negated a net change in complex-
ity indices. In addition, an isoproterenol-induced increase in
activation rate in this study may not have reached the crit-
ical threshold above which further fibrillatory conduction
develops.
Electrogram Complexity, Termination of AF and Clinical
Outcome
Consistent with the findings of a prior study, CI and FI
were lower when AF terminated than when AF persisted dur-
ing APVI.10 Furthermore, electrogram amplitude was larger
in patients who had termination of AF than in whom AF
persisted. However, baseline DF was not predictive of ter-
mination of AF during AF. It is likely that APVI eliminates
high frequency drivers (high DF) that are likely to reside
within the PVs and their antral regions. However, complex
and fractionated electrograms may indicate mechanisms of
AF likely to be reentrant, localized outside the PVs, and
not eliminated by APVI. Therefore, a higher prevalence of
complex electrograms in patients in whom AF persists after
APVI may indicate extra-PV mechanisms that contribute to
perpetuation of AF. This may also explain why complexity
and fractionation (but not DF) of electrograms recorded in
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the coronary sinus was predictive of recurrent AF after APVI
in patients with paroxysmal AF.
In an effort to assess the role of functional effects of
AF on electrogram complexity and fractionation, the ratio
of CI and FI in AF to SR was compared among patients
who did and did not have termination of AF during APVI.
The FIAF/SR and CIAF/SR were higher among patients whose
AF persisted than terminated during ablation. This observa-
tion may suggest that functional and/or structural changes
in the myocardium that develop or become manifest dur-
ing AF play a critical role in the occurrence of complex
electrograms.
Prior studies
In a prior study, AF was eliminated by targeting fibrillar
myocardium that displayed similar characteristics to type
II electrograms in this study.4 Unlike in the prior study,
there was no relationship between the efficacy of ablation
and type of electrograms in this study. However, in this
study electrogram analysis was performed only within the
CS and specific electrogram types were not targeted for
ablation.
Study Limitations
A limitation of this study is the relatively small sample
size. A second limitation is that only CS electrograms were
analyzed. Conclusions on the global spatiotemporal orga-
nization of AF cannot be made based on the findings of
this study. However, electrograms recorded from a fixed and
stable multipolar electrode catheter enabled a robust com-
parison of electrograms recorded from the very same site
during SR and AF. Finally, only patients with paroxysmal
AF were included in this study; whether these findings can
be extrapolated to patients with persistent AF remains to be
determined in future studies.
Clinical Implications
The findings of this study suggest that mapping of com-
plex electrograms during SR is unlikely to be adequate to
identify drivers of AF. Rather, it seems necessary to look for
complex electrograms during AF. These observations may
suggest that functional characteristics of the atrial tissue, in
addition to structural properties, play a key role in develop-
ment of complex electrograms, some of which may become
manifest only during AF.
It also appears that mapping both in time- and
frequency domains is necessary to identify drivers of AF.
Although high frequency focal sources may be better iden-
tified using spectral analysis, complex electrograms as iden-
tified in time-domain may be more helpful to map reentrant
drivers of AF. Nevertheless, time- and frequency-domain
characteristics of complex electrograms that indicate spe-
cific underlying drivers of AF need to better defined in
future prospective studies utilizing high-density multisite
mapping and objective parameters to assess electrogram
characteristics.
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